Document is current

Any future updates will be listed below

News: Immuntherapiekombis palliativ und TKI als Adjuvans bei EGFR-NSCLC

Crossref DOI link: https://doi.org/10.1007/s15033-020-1896-0

Published Online: 2020-09-01

Published Print: 2020-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark